Publication Name	World Journal of Hepatology
Manuscript ID	6991
Country	Denmark

Received	2013-10-31 14:04
Peer-Review Started	2013-11-01 10:27
To Make the First Decision	2014-01-08 15:03
Return for Revision	2014-01-13 10:10
Revised	2014-01-22 17:25
Second Decision	2014-02-20 20:05
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-02-20 20:19
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-03-18 14:18
Typeset the Manuscript	2014-05-08 20:32
Publish the Manuscript Online	2014-05-20 15:05

ISSN	1948-5182 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	Sara Heebøll, Karen Louise Thomsen, Steen B Pedersen, Hendrik Vilstrup, Jacob George and Henning Grønbæk
Funding Agency and Grant Number	Funding Agency Grant Number Aarhus University and the Danish Council for Independent Research, Medical Sciences 11-107912 Danish Strategic Research Council 10-093499 NOVO Nordisk Foundation to Grønbæk H Robert W to George J Sydney Medical University of Sydney National Health and Medical Research Council of Australia (NHMRC) Program 1053206 National Health and Medical Research Council of Australia (NHMRC) Program 632630 National Health and Medical Research Council of Australia (NHMRC) Program 1049857
Corresponding Author	Henning Grønbæk, MD, PhD, Professor of Experimental Hepatology, Department of Hepatology and Gastroenterology, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark. henning.gronbaek@aarhus.rm.dk
Key Words	Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Steatosis; Resveratrol; AMP-activated protein kinase; Silent information regulation-2 homolog 1; Anti-oxidants; Anti-inflammatory agents; Animal studies; Clinical trial
Core Tip	Henning Gr?nb?k, MD, PhD, Professor of Experimental Hepatology, Department of Hepatology and Gastroenterology, Aarhus University Hospital, N?rrebrogade 44, 8000 Aarhus C, Denmark. henning.gronbaek@aarhus.rm.dk
Publish Date	2014-05-20 15:05
Citation	Heebøll S, Thomsen KL, Pedersen SB, Vilstrup H, George J, Grønbæk H. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. World J Hepatol 2014; 6(4): 188-198
URL	http://www.wjgnet.com/1948-5182/full/v6/i4/188.htm
DOI	http://dx.doi.org/10.4254/wjh.v6.i4.188

Full Article (PDF)	WJH-6-188.pdf
Full Article (Word)	WJH-6-188.doc
Manuscript File	6991-Review.docx
Answering Reviewers	6991-Answering reviewers.pdf
Copyright License Agreement	6991-Copyright assignment.pdf
Peer-review Report	6991-Peer review(s).pdf
Scientific Editor Work List	6991-Scientific editor work list.doc